Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

TOBI Podhaler

Generic name: Tobramycin

FDA application holder: Viatris

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is TOBI Podhaler?
TOBI Podhaler is a brand name of Tobramycin, a prescription medicine. The FDA NDC Directory lists 1 TOBI Podhaler product in 1 strength and form.
Who makes TOBI Podhaler?
Viatris holds the FDA application for TOBI Podhaler (NDA201688, approved March 22, 2013).
Is there a generic or store brand of TOBI Podhaler?
Other products of Tobramycin are listed with the FDA, but none in exactly the same strength and form as a TOBI Podhaler product.
Has TOBI Podhaler been recalled?
No recall linked to TOBI Podhaler products (by their NDC code or label) appears in the FDA enforcement reports we use.

What TOBI Podhaler is

Each TOBI Podhaler product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Tobramycin · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
tobramycin 28 mg
capsule (oral, respiratory (inhalation))
TOBI Podhaler None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Tobramycin →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of TOBI Podhaler products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA201688ViatrisMarch 22, 20131

Companies that list TOBI Podhaler

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of TOBI Podhaler products.

Recalls

No recall linked to TOBI Podhaler products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers